Jump to Content Jump to Navigation
About us

aprimeo diagnostics

Who we are

aprimeo diagnostics, an R‑Biopharm company, is a dynamic and rapidly growing company based in the Rhine-Main area near Frankfurt, Germany. Focused on the distribution of innovative, next-level diagnostic solutions, our partnership with BOSCH Healthcare Solutions (BHCS) enables us to provide the innovative molecular diagnostic platform Vivalytic to healthcare professionals, enabling them to make the best therapy decision possible for their patients each and every day.

Since June 2022, we have also been the first official Bosch Premium Partner due to our extensive experience with the system.

Aprimeo BOSCH Premium Partner Logo 848px EN

Our Vision. Our Promise.

Our vision is to enable healthcare professionals to improve patients’ lives always and everywhere by providing access to convenient and innovative near-patient testing.
Driven by creating value, enhancing efficiency and focusing on your needs, we aspire to be the most flexible, reliable and trusted partner in diagnostics, today and tomorrow.

Meet the Management Team

aprimeo diagnostics is fueled by the passion, innovation and entrepreneurial spirit of Frank and Diana. Setting itself apart from its peers by exceeding customers’ yet unmet needs and demands, is a sound foundation for continuous growth and substantial success in the upcoming years.

Frank Apostel, Ph.D.

Frank Apostel, Ph.D.

Managing Director and Partner

Frank Apostel was appointed Managing Director and Partner for aprimeo diagnostics in 2019. Prior to aprimeo diagnostics he was Vice President of Business Development at R‑Biopharm AG for almost seven years. Before joining R‑Biopharm, he worked at QIAGEN GmbH and Eppendorf AG in a variety of business development, product management and sales management roles.

Frank Apostel graduated in Chemistry and earned his Ph.D. in Molecular Medicine from the University Hamburg, Germany.

Diana Martens

Diana Martens

Managing Director and Partner

Diana Martens is Managing Director and Partner at aprimeo diagnostics since 2019. She has previously worked at R‑Biopharm AG with more than 10 years of experience in diagnostics and life sciences. As a Director for Business Development at R‑Biopharm AG she was responsible for the management of international and multidisciplinary projects. Earlier, she had roles of increasing responsibility in sales of molecular diagnostics and R&D of R‑Biopharm AG.

Diana Martens graduated from the University of Applied Sciences Emden, Germany, with a diploma in Biotechnology.

Loading …